METHODS	A double-blind , randomized-controlled trial was conducted among consecutive cirrhotic patients who had either recovered from SBP ( secondary prophylaxis ) or who were at a high risk for the development of SBP ( low ascitic fluid protein or serum bilirubin 2.5 mg/dl ; primary prophylaxis ) .\